請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/31911
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江伯倫(Bor-Luen Chiang) | |
dc.contributor.author | Han-Fang Cheng | en |
dc.contributor.author | 鄭涵方 | zh_TW |
dc.date.accessioned | 2021-06-13T03:24:13Z | - |
dc.date.available | 2006-08-04 | |
dc.date.copyright | 2006-08-04 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-29 | |
dc.identifier.citation | Annes, J. A., Munger, J. S. ; Rifkin, D. B. M. Making sense of latent TGFβ activation. J. Cell Sci. 116, 217-224 (2003).
Annacker, O. et al. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166, 3008-3018 (2001). Annes, J. P., Chen, Y., Munger, J. S. & Rifkin DB. Integrin αvβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1. J. Cell Biol. 165, 723-734 (2004). Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naïve T cells. J. Exp. Med. 199, 1401-1408 (2004). Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396 (1996). Bennett, C. L. & Ochs, H. D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr. Opin. Pediatr. 13, 533-538 (2001). Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genetics 27, 20-21 (2001). Bettelli, E., Dastrange, M. & Oukka, M. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102, 5138-5143 (2005). Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 27, 68-73 (2001). Chen, M. L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H. & Khazaie, K. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc. Natl. Acad. Sci. USA. 102, 419-424 (2005). Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G. & Wahl, S. M. Conversion of peripheral CD4+CD25- naïve T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003). Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. & Weiner, H. L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 (1994). de la Rosa, M., Rutz, S., Dorniger, H. & Scheffold, A. Interleukin-2 is essential for CD4+ CD25+ T cell function. Eur. J. Immunol. 34, 2480-2488 (2004). Elliott, R. L. & Blobe, G. C. Role of transforming growth factor β in human cancer. J. Clin. Oncol. 23, 2078-2093 (2005). Fahlen, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A. & Powrie, F.T cells that cannot respond to TGF-β escape control by CD4+ CD25+ regulatory T cells. J. Exp. Med. 201, 737-46 (2005). Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R. & Neurath, M. F. Cutting edge: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004). Fisson, S. et al., Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 198, 737-746 (2003). Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336 (2003). Fontenot, J. D. & Rudensky, A. Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 4, 331-337 (2005). Gershon, R.K. & Kondo, K. Infectious immunological tolerance. Immunology 21, 903-914 (1971). Ghiringhelli, F. CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 202, 1075-1085 (2005). Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nat. Rev. Immunol. 2, 46-53 (2002). Gorelik, L., Constant, S. & Flavell, R. A. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195, 1499-1505 (2002). Gorelik, L., Fields, P.E. & Flavell, R. A. Cutting edge: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165, 4773–4777 (2000). Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H. & Flavell, R. A. CD4+ CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100, 10878-10883 (2003). Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003). Hsieh, C. S. et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267-277 (2004). Huber, S. et al. Cutting edge: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+ CD25+ T cells. J. Immunol. 173, 6526-6531 (2004). Hyytiainen, M., Penttinen, C. & Keski-Oja, J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit. Rev. Clin. Lab. Sci. 41, 233-264 (2004). Itoh, M. et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317-5326 (2000). Jonuleit, H. et al. Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J. Exp. Med. 196, 255-260 (2002). Jordan, M. S. et al. Thymic selection of CD4+ CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 30, 136-144 (2000). Kanangat S., Blair P., Reddy R., Deheshia M., Godfrey V., et al. Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur. J. Immunol. 26, 161-165 (1996). Khattri R., Cox T., Yasayko S. A. & Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337-342 (2003). Klein, L., Khazaie, K. & von Boehmer, H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100, 8886-8891 (2003). Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219 - 1227 (2005). Kulkarni, A. B., Huh, C. G., Becker, D. et al. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770-774 (1993). Ludviksson, B. R., Seegers, D., Resnick, A. S. & Strober, W. The effect of TGF-β1 on immune responses of naïve versus memory CD4+ TH1/TH2 T cells. Eur. J. Immunol. 30, 2101-2111 (2000). Malek, T. R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167-178 (2002) Monteleone, G., Kumberova, A., Croft, N. M., McKenzie, C., Steer, H. W. & MacDonald, T. T. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108, 601-609 (2001). Monteleone, G., Pallone, F., MacDonald, T.T. Smad7 in TGF-β-mediated negative regulation of gut inflammation. Trends Immunol. 25, 513-517 (2004). Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J. J. & Curotto de Lafaille, M. A. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115,1923-1933 (2005). Murphy-Ullrich, J. E. & Poczatek, M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 11, 59-69 (2000). Nakamura, K., Kitani, A. & Strober, W. Cell contact-dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194, 629-644 (2001). Nakao, A. Is TGF-β1 the key to suppression of human asthma? Trends Immunol. 22, 115-118 (2001). Nishizuka, Y. & Sakakura, T. Thymus and reprodution: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166, 753-755 (1969). Ostroukhova, M., Qi, Z., Oriss, T. B., Dixon-McCarthy, B., Ray, P. & Ray, A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β. J. Clin. Invest. 116, 996-1004 (2006). Paust, S., Lu, L., McCarty, N. & Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101, 10398-10403 (2004). Peng, Y., Laouar, Y., Li, M. O., Green, E. A. & Flavell, R. A. TGF-β regulates in vivo expansion of Foxp3-expressing CD4+ CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101, 4572-4577 (2004). Piccirillo, C. A. et al. CD4+ CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196, 237-246 (2002). Powell, B. R., Buist, N. & Stenzel, P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 100, 731-737 (1982). Rao, P. E., Petrone, A. L. & Ponath, P. D. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174, 1446-1455 (2005). Sad, S. & Mosmann, T. R. Single IL-2-secreting precursor CD4 T cell can develop into either TH1 or TH2 cytokine secretion phenotype. J. Immunol. 153, 3514-3522 (1994). Sakaguchi, S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004). Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995). Schramm, C. et al. TGF-β regulates the CD4+ CD25+ T-cell pool and the expression of Foxp3 in vivo. Int. Immunol. 16, 1241-1249 (2004). Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F. & Ziegler, S. F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672-37679 (2001). Shevach, E. M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400 (2002). Shevach, E. M. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18, 423-449 (2000). Shi, Y. & Massague, J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700 (2003). Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+ CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte–associated antigen. Int. Immunol. 10, 1969-1980 (1998). Tang, Q. et al. Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34, 2996-3005 (2004). Tau, G. Z. et al. Interferon-γ signaling alters the function of T helper type 1 cells. J. Exp. Med. 192, 977–986 (2000). Thornton, A. M., Donovan, E. E., Piccirillo, C. A. & Shevach, E. M. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+ CD25+ T cell suppressor function. J. Immunol. 172, 6519-6523 (2004). Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. & Sharpe, A. H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 41-47 (1995). Tommasini, A. et al. X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin. Exp. Immunol. 130, 127-130 (2002). Vieira, P. L. et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172, 5986-5993 (2004). Von Boehmer, H. Dynamics of suppressor T cells: in vivo veritas. J. Exp. Med. 198, 845-849 (2003). Walker, L. S., Chodos, A., Eggena, M., Dooms, H. & Abbas, A. K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003). Walker, M. R. et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells. J. Clin. Invest. 112:1437-1443 (2003). Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genetics 27, 18-20 (2001). Yagi, H. et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16, 1643-1656 (2004). | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/31911 | - |
dc.description.abstract | 免疫系統能使人體免除外來的病原體的威脅。後天免疫系統能分辨自體抗原以及外來抗原:對外來抗原產生反應而消滅外來威脅、保護人體;而對自體抗原有耐受性,避免攻擊自身。所謂「免疫耐受性」(immune tolerance)係指免疫系統對於某些抗原的不反應性。近年來研究發現有一群T細胞,又名「調節性T細胞」(regulatory T cells)對於周邊免疫耐受性(peripheral tolerance)扮演了極重要的角色。調節性T細胞主動地抑制自體免疫疾病及過敏反應的產生,維持免疫系統的恒定。現已發現一轉錄因子—Foxp3可做為調節性T細胞的分子標記,而且在生理情況下調節性T細胞的分化與發育必須要有Foxp3分子的表現。許多研究團隊已發現若使未分化的T細胞過度表現Foxp3,可有效誘導其分化為調節性T細胞,並且這群「調節性T細胞」有治癒自體免疫疾病或是過敏疾病的療效。另外引起我們注意的是細胞激素—TGF-β。TGF-β是一個多功用的分子,特別是一種抑制免疫反應的細胞激素。許多研究報告已指出TGF-β參與調節性T細胞引起的免疫耐受性,但其機制未明。
在此研究中,我們製作了帶有轉錄因子Foxp3的重組慢病毒(recombinant lentivirus)以及帶有TGF-β的重組慢病毒,用這兩株病毒分別感染T細胞株,使其過度表現Foxp3或是TGF-β,而顯現調節性T細胞的表型。接著我們研究了在這些被病毒感染的細胞株中,Foxp3的表現量、TGF-β分子分泌量,以及在細胞膜上TGF-β分子的表現量的調節。而後我們研究了Foxp3或是TGF-β過度表現是否會調節一些參與TGF-β訊息傳遞路徑的分子,如TGF-β受器,Smad2以及Smad3。我們發現T 細胞株被帶有TGF-β的重組慢病毒感染而過度表現TGF-β之後,被刺激後,介白質-2的分泌量會下降,且會誘發表現Foxp3。而若以同樣方法使T細胞株表現Foxp3,在刺激過後,TGF-β受器,第二型TGF-β以及Smad3的表現量都會上升。而過度表現Foxp3的T細胞株在被TGF-β1刺激之後,Smad2磷酸化的情形會較一般的T細胞株更為明顯。這些研究結果進一步探討了轉錄因子Foxp3誘導T細胞分化為調節性T細胞的機轉,以及TGF-β如何調節免疫抑制功能,並了解Foxp3以及TGF-β的相互作用,以更加闡明調節性T細胞發育與其作用的分子機制。 | zh_TW |
dc.description.abstract | The immune system has evolved the mechanisms to recognize and eliminate threats, as well as to avoid deleterious responses such as self-destruction and inflammation. Such unresponsiveness to self-antigens and nonpathogenic environmental antigens is called immune tolerance. Regulatory T cells (Tregs) have been demonstrated to play a critical role in maintaining immune tolerance and homeostasis by actively suppressing the development of autoimmune and allergic responses. It has already been reported that the forkhead family transcription factor Foxp3 is critically important for the development and function of the regulatory T cells. It is expressed in CD4+ CD25+, but not CD4+ CD25- T cells and acts as a silencer of cytokine gene promoters in CD4+ CD25+ Treg cells. In addition, studies have shown that the cytokine TGF-β produced by Tregs potently suppresses immune responses. Nonetheless, little is known about the correlation between Foxp3 and TGF-β. In this study, we investigated the effect of overexpression of TGF-β through lentiviral system upon IL-2 secretion and Foxp3 expression in human leukemia cells. Likewise, we investigated the effect of Foxp3 overexpression on the protein level of TGF-β and the components of TGF-β-mediated signaling cascade, such as Smad2 and Smad3. Finally, we examined the effect of Foxp3 on TGF-β1 signaling. We addressed that TGF-β overexpression suppresses stimulation-induce IL-2 hypersecretion and induces Foxp3 expression. Overexpression of Foxp3 had little influence on TGF-βsecretion while significantly enhanced surface-bound TGF-β TGF-βRII and Smad3. Furthermore, we described that Foxp3-overexpressed T cells were more susceptible to TGF-β1-induced phosphorylation of Smad2. These findings help to elucidate the molecular mechanisms of development and action of regulatory T cells. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T03:24:13Z (GMT). No. of bitstreams: 1 ntu-95-R93450005-1.pdf: 1115304 bytes, checksum: 91173c7c2198aee8f8631cf5593c12eb (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | 誌謝 ………………………………………………………………..... i
摘要 …………………………………………………………………. iii Abstract ………………………………………………………………. v Contents ….…………………………………………………………… vi Chapter I Introduction ……………………………………………… 1 1.1 . Regulatory T cells ………………………………………………. 2 1.2. Forkhead box P3 (Foxp3) ………………………………………. 9 1.3. Transforming Growth Factor-beta ……………………………… 13 1.4. Aims……………………………………………………………... 19 Chapter II Materials & Methods …………………………………. 20 2.1. Materials ………………………………………………………. 21 2.2. Methods ………………………………………………………… 27 Chapter III Results ………………………………………………… 33 Chapter IV Discussion …………………………………………….. 43 Figures ……………………………………………………………..... 51 References …………………………………………………………... 69 Appendix ……………………………………………………………. 80 | |
dc.language.iso | en | |
dc.title | T細胞過度表現轉形生長因子-β或Foxp3對其調節功能的影響 | zh_TW |
dc.title | Overexpression of TGF-β or Foxp3 in T Cells on Their Regulatory Function | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳進庭,張百恩 | |
dc.subject.keyword | 調節性T細胞,轉型生長因子, | zh_TW |
dc.subject.keyword | regulatory T cells,Foxp3,TGF-beta, | en |
dc.relation.page | 84 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-29 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 1.09 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。